Aim & Scope
An intentional Journal which is published quarterly in English. Journal publishes papers, review articles, and short communications dealing with drug controlled release systems, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering and materials science.Pharmaceutical Chemistry, Pharmaceutical Technology, pharmacognosy, natural product research, pharmaceutics, novel drug delivery, pharmaceutical & medicinal chemistry, computational chemistry and molecular drug design, pharmacology, pharmaceutical analysis, pharmacy practice, clinical and hospital pharmacy etc. IJPR would take much care in making your article published without much delay with your kind cooperation. IJPR hopes that Researchers, Research scholars, Academician, Industrialists etc. would make use of this research publications for the development of pharmaceutical science and technology.
Editorial policy International Journal of Pharmaceutical Research (IJPR) is committed to the timely publication of peer-reviewed articles in journals. IJPR requires all authors to comply fully with current ethical standards for publication in their disciplines. Manuscripts submitted to the journal must represent reports of original research, and the original data must be available for review by the editor if necessary. All authors of a manuscript must have agreed to its submission and are responsible for its content, including appropriate citations and acknowledgments, and must also have agreed that the corresponding author has the authority to act on their behalf in all matters pertaining to publication of the manuscript. By submission of a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, and is not being considered for publication elsewhere. When submitting papers for publication, it is expected that the authors will provide written assurance and describe the novelty of their work or in the approach taken in their research in a covering letter.
Apart from any fair dealing for the purpose of research or personal study, or any critical suggestion or review, no part of the publication can be reproduced, stored, or transmitted, in any form or by any means without prior permission of the editor, IJPR. IJPR and /or its publisher /or editorial members cannot be held responsible for any error or for any consequences arising from the use of the information contained in this journal. The copy of the journal will be sent to the corresponding authors only by ordinary post and soft copy of the articles will be delivered through e-mail only. If the copy of journal return, due to incomplete or incorrect or changed address of the authors, in such cases the authors will be responsible for updating the correct address. It will be illegal to acquire copies of IJPR journal from other sources; one cannot resale or gives away the copies of journal for the commercial or library purpose. The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. It is the responsibility of authors/ contributors to obtain permissions for reproducing any copyrighted material. A copy of the permission obtained must be submitted when required.
IJPR insists on ethical practices in both human and animal experimentation. Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of aesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section. Authors must be careful when they reproduce text, tables or illustrations from other sources. Plagiarism will be viewed seriously. All accepted papers are subject to editorial changes.
All rights are reserved to Editor-in-chief, IJPR.
Submission of manuscripts
Authors are strongly encouraged to submit their manuscripts electronically by online manuscript submission system of IJPR ( www.ijpronline.com). Review process
All manuscripts are anonymously reviewed by the editors, members of the editorial board, advisory board or qualified reviewers. When a manuscript is submitted to the journal, it is given a number and assigned to two reviewers. The reviewers operate under strict guidelines and are expected complete their reviews quickly. Within 6 to 8 weeks after submission, the corresponding author will be notified of the editor’s decision to accept without change, recommended for modification, further review, or reject. When modifications are requested, the corresponding author must either submit the modified version or withdraw the manuscript. Manuscripts that have been rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmit, and the former manuscript number should be provided in the appropriate field on the submission form.
Online Submission of Manuscripts:
All manuscripts must be submitted on-line through the website www.ijpronline.com. (Please give direct link) First time users will have to register at this site. Submit articles after logging into the site using their user name and password. Authors do not have to pay for submission or processing of articles. The contributor may provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but who are not the members of the institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. When you submit an article, the following items must be included. Manuscripts that do not adhere to the following instructions will be returned to the corresponding revision before undergoing peer review.
1. Cover letter- Format available on website.
2. Article Type-Review article/Research article/Short communication
4. Corresponding Author- Name
5. Co-Authors- Name
6. Corresponding author- Address, City, Zip Code, Mobile number
7. Title- Times New Roman, 14 sizes.
8. Abstract- 150-250 words
9. Key words- 3-6
10. Upload article- (Article File)
(a) Submit as a .doc (MS 2003 version) /.rtf file. Do NOT submit as a .docx or PDF file.
(b) Article file should be including following: Title, Abstract, Keywords, Main text including Tables, Graphics, Photograph, Figure and References.
(c) Max size not more then 4 MB
11. Note- On successful uploading of your article will get one Manuscript ID number in your account for all future correspondence. Preparation of Manuscript
The manuscripts must be type-written in clear, grammatically correct English with no typographical errors. Manuscripts that do not meet the minimal requirements for English grammar and composition will be rejected immediately. Manuscripts with text that is faint or illegible or with substandard illustrations will be returned to the authors.
Neatly type every portion of the manuscript with 1.5 times of spacing (a minimum of 6 mm between lines) and 2.54 cm margins on all sides, including figure legends, table footnotes and references. The manuscript should be prepared and numbered consecutively as follows: Title page, Abstract, Introduction, Materials and methods, Results and discussion, Conclusion, Acknowledgements, References, Tables and Figures.
Use Times New Roman 12 sizes font type, throughout the manuscript. Leave one space after a comma, except in chemical names. For the identification of pharmaceutical substances, the International Nonproprietary Names (INN) proposed and recommended by the WHO should be used. For the units of measurement, the use of the International System of Units (SI) is recommended: m (meter), g (gram), kg (kilogram), μg (microgram), s (second), min (minute), h (hour), d (day), y (year), l (litre), μl (microlitre), ng/ml not ng•ml-1 and r/min not rpm. Excessive abbreviations should be avoided and abbreviations other than those acknowledged, uniform and standard should be contained in brackets at their first use.
Title page: Please give the title (capital for first character), running title (not to exceed 50 characters and spaces), name of each author and an asterisk placed after the name of the corresponding author, address (es) of the institution(s) at which the work was performed, each author’s affiliation, and a footnote including the complete mailing address, a single telephone number, and a single e-mail address for the corresponding author.
Abstract: A structured abstract not exceeding 250 words should be arranged. Avoid abbreviations and references, and do not include diagrams. The abstract with keywords should be typed on a separate sheet.
Keywords: Below the abstract, type 3-6 keywords or short phrases suitable for indexing.
Introduction: The introduction should not be an extensive literature review although it should provide sufficient background information for the reader to understand and evaluate the results of the present study without referring to previous publications on the same topic.
Materials and methods: The Methods section should only include information that was available at the time the study was planned or protocol written; all information obtained belongs to the results section. Mentioned model, make and name of manufacturer for each instrument used in the study.
Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age and sex to clear, authors should explain their use when they are included in a study report; for example, authors should explain why only subjects of certain were excluded. The guiding principle should be clarity about how and why a study was done in a particular way. When authors use variables such define how they measured the variables and justify their relevance.
Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Chemicals used, including generic name(s), dose(s), and route(s) of administration. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions concealment of allocation to treatment groups, and the method of masking (blinding).
Ethics: When reporting studies on human, indicate whether the procedures followed were in accordance with the ethical standards of the responsible (institutional or regional) and When reporting experiments on animals, indicate whether the institution’s or a national research national law on the care and use of laboratory animals was followed. Animal be as humane as possible and the details of anaesthetics and analgesics used should be clearly stated. The ethical standards of experiments must guidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider any paper which is ethically unacceptable. A statement permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.
Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). (such as dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Terms in statistics, such as 'random' (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical terms, Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001.
Results and Discussion: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in illustrations; emphasize or summarize only important observations. Extra or supplementary materials and technical detail can be placed in an but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. "Where scientifically appropriate, such as age and sex should be included. Include summary of key findings, Strengths (study question, study design, data collection, analysis and interpretation); what this study adds to the available evidence, effects on patient care and health Controversies raised by this study; and Future research directions. Do not repeat in detail data or other material given in the Introduction. In particular, contributors should avoid making statements costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed.
Conclusion: A short, paragraph summarizing the most important finding(s) of the research is required.
Acknowledgments: The source of any financial support, gifts, technical assistance and advice received for the work being published must be indicated in the Acknowledgments section.
References: Literature citations in the text must be indicated by Arabic numerals in square bracket. Each reference separately in the order it appears in the text. The references should be cited at the end of the manuscript in the order of their appearance in the text.
Standard Journal Article
Author(s) of article (Surname initials), Title of article, Journal title (full name), Year of publication; Volume number (issue number): Page numbers. (If more than six authors, then first three shall be listed followed by et al.) Shah DP, Jani GK, Modification and Characterization of Gellan Gum, Pharmaceutical Technology, 2009; 33(7): 48-58.
Books and other Monographs
Author(s) of Book (Surname initials). Title of Book. Edition. Publisher; Place of publication; Year of publication.Personal author(s)
Eisen HN. Immunology: an introduction to molecular and cellular principles of the immune response. 5th Edition. New York: Harper and Row; 1974.
Chapter or Article in a book
Author(s) of Chapter (Surname initials). Title of Chapter. In: Editor(s) name, Editors. Title of Book. Place of publication: Publisher; Year of publication, Page numbers.
Kelly HW and Sorknes CA. Asthma, Dipiro JT, Talbert RL, Yee GC, Matzke TR, Wells BG, Posey LM, Pharmacotherapy- A Pathophysiological Aproch, Sixth Edition, The McGraw-Hill; 2005.504
Larsen CE, Trip R, Johnson CR, inventors; Novoste Corporation, assignee. Methods for procedures related to the electrophysiology of the heart. US patent 5529 067. 1995.
LIMITATIONS FOR PAPERS SUBMITTED UNDER EACH CATEGORY
|Article type||Abstract: No. of words||Key words: No. of words||Running title No. of characters||Tables/Figures|
|Review Article||< 250||3-6||< 50||Max. total of Five|
|Research Article||< 250||3-6||< 50||Max. total of Eight|
|Short Communication||NR||NR||< 50||Max total of Three|